MetaCap

Corvus Pharmaceuticals (CRVS) News

NASDAQ: CRVSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.67-0.34 (-3.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CRVS news summary

We found 6 recent headlines mentioning Corvus Pharmaceuticals (CRVS): 0 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, CRVS is down 3.40% at $9.67. The most recent story, "Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference in London", was published by GlobeNewswire on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Corvus Pharmaceuticals headlines

Stocks mentioned alongside CRVS

Compare CRVS